SouthState’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10K Buy
38
+26
+217% +$6.86K ﹤0.01% 720
2026
Q2
$2.65K Sell
12
-19
-61% -$5.26K ﹤0.01% 898
2026
Q1
$9.16K Sell
31
-4
-11% -$1.19K ﹤0.01% 667
2025
Q4
$9.6K Buy
35
+1
+3% +$272 ﹤0.01% 696
2025
Q3
$9.19K Sell
34
-156
-82% -$42.4K ﹤0.01% 674
2025
Q2
$52.4K Sell
190
-313
-62% -$85.1K ﹤0.01% 502
2025
Q1
$133K Buy
+503
New +$124K 0.01% 389
2023
Q3
– Sell
-130
Closed -$24.1K – 641
2023
Q2
$24.1K Hold
130
– – ﹤0.01% 396
2023
Q1
$24.9K Hold
130
– – ﹤0.01% 423
2022
Q4
$21.9K Sell
130
-18
-12% -$3.13K ﹤0.01% 462
2022
Q3
$26K Sell
148
-31
-17% -$6.13K ﹤0.01% 437
2022
Q2
$36K Buy
179
+84
+88% +$17.8K ﹤0.01% 439
2022
Q1
$23K Buy
95
+46
+94% +$10.8K ﹤0.01% 519
2021
Q4
$11K Buy
49
+18
+58% +$3.96K ﹤0.01% 554
2021
Q3
$6K Buy
+31
New +$6.28K ﹤0.01% 515

Other funds holding CME

SouthState's CME Position: Q3 2026 in Review

SouthState increased its CME Group (CME) stake by 217% in Q3 2026, buying an estimated $6.86K and bringing the position to 38 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #720.

SouthState first reported a position in CME in Q3 2021 and has held it in 15 quarters since. The position peaked at $133K in Q1 2025. 1,528 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • SouthState held 38 shares of CME Group worth $10K as of Q3 2026.
  • SouthState bought 26 CME Group shares in Q3 2026, an estimated $6.86K.
  • CME Group made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #720 holding.
  • SouthState first reported a position in CME Group in Q3 2021 and has held it in 15 quarters since.
  • SouthState's CME Group position peaked at $133K in Q1 2025.
  • 1,528 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.